A process for the preparation of 5-(haloacetyl)-8-(substituted oxy)-(1H)-quinolin-2-ones

Details for Australian Patent Application No. 2004226212 (hide)

Owner Novartis AG

Inventors Schilling, Hanspeter; Lohse, Olivier; Penn, Gerhard

Agent Davies Collison Cave

Pub. Number AU-B-2004226212

PCT Pub. Number WO2004/087668

Priority 60/459,724 02.04.03 US

Filing date 1 April 2004

Wipo publication date 14 October 2004

Acceptance publication date 21 February 2008

International Classifications

C07D 215/26 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Event Publications

13 October 2005 PCT application entered the National Phase

  PCT publication WO2004/087668 Priority application(s): WO2004/087668

21 February 2008 Application Accepted

  Published as AU-B-2004226212

19 June 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004226215-Oxime derivatives and their use as pharmaceutically active agents

2004226207-4-substituted quinolein derivatives with antimicrobial activity